128 related articles for article (PubMed ID: 1467980)
1. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists.
Svensson AL; Alafuzoff I; Nordberg A
Brain Res; 1992 Nov; 596(1-2):142-8. PubMed ID: 1467980
[TBL] [Abstract][Full Text] [Related]
2. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
3. Identification of three muscarinic receptor subtypes in rat lung using binding studies with selective antagonists.
Fryer AD; el-Fakahany EE
Life Sci; 1990; 47(7):611-8. PubMed ID: 2402185
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of muscarinic receptors in the uterus of oestrogen-primed and pregnant rats.
Munns M; Pennefather JN
Br J Pharmacol; 1998 Apr; 123(8):1639-44. PubMed ID: 9605571
[TBL] [Abstract][Full Text] [Related]
5. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
6. Regional differences in the binding of selective muscarinic receptor antagonists in rat brain: comparison with minimum-energy conformations.
Messer WS; Ellerbrock BR; Smith DA; Hoss W
J Med Chem; 1989 Jun; 32(6):1164-72. PubMed ID: 2724292
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic binding sites of the pig intravesical ureter.
Hernández M; García-Sacristán A; Orensanz LM
J Auton Pharmacol; 1995 Oct; 15(5):351-9. PubMed ID: 8744975
[TBL] [Abstract][Full Text] [Related]
8. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain.
Aubert I; Cécyre D; Gauthier S; Quirion R
Eur J Pharmacol; 1992 Jul; 217(2-3):173-84. PubMed ID: 1425938
[TBL] [Abstract][Full Text] [Related]
9. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.
Watson M; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 1986 May; 237(2):419-27. PubMed ID: 3754581
[TBL] [Abstract][Full Text] [Related]
10. Characterization of [3H]AF-DX 116 binding sites in the rat brain: evidence for heterogeneity of muscarinic-M2 receptor sites.
Araujo DM; Lapchak PA; Regenold W; Quirion R
Synapse; 1989; 4(2):106-14. PubMed ID: 2781463
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptor subtypes in human nasal mucosa: characterization, autoradiographic localization, and function in vitro.
Okayama M; Mullol J; Baraniuk JN; Hausfeld JN; Feldman B; Merida M; Shelhamer JH; Kaliner MA
Am J Respir Cell Mol Biol; 1993 Feb; 8(2):176-87. PubMed ID: 8427708
[TBL] [Abstract][Full Text] [Related]
13. Characterization of muscarinic acetylcholine receptors in cultured adult skin fibroblasts: effects of the Swedish Alzheimer's disease APP 670/671 mutation on binding levels.
Vestling M; Cowburn RF; Venizelos N; Lannfelt L; Winblad B; Adem A
J Neural Transm Park Dis Dement Sect; 1995; 10(1):1-10. PubMed ID: 8619905
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of alkylating agents on the multiple muscarinic receptor subtypes linked to activation of phospholipase C by carbachol in rat brain cortical membranes.
Sallés J; Wallace MA; Fain JN
J Pharmacol Exp Ther; 1993 Feb; 264(2):521-9. PubMed ID: 8437104
[TBL] [Abstract][Full Text] [Related]
15. Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists.
Vanderheyden P; Gies JP; Ebinger G; De Keyser J; Landry Y; Vauquelin G
J Neurol Sci; 1990 Jun; 97(1):67-80. PubMed ID: 2370560
[TBL] [Abstract][Full Text] [Related]
16. A minority of muscarinic receptors mediate rabbit tracheal smooth muscle contraction.
Mahesh VK; Nunan LM; Halonen M; Yamamura HI; Palmer JD; Bloom JW
Am J Respir Cell Mol Biol; 1992 Mar; 6(3):279-86. PubMed ID: 1540392
[TBL] [Abstract][Full Text] [Related]
17. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites.
Delmendo RE; Michel AD; Whiting RL
Br J Pharmacol; 1989 Feb; 96(2):457-64. PubMed ID: 2924085
[TBL] [Abstract][Full Text] [Related]
18. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
Norman AB; Creese I
Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of cholinergic muscarinic receptors coupled to phosphoinositide metabolism in immature rat brain.
Candura SM; Tonini M; Baiardi P; Manzo L; Costa LG
Brain Res Dev Brain Res; 1995 May; 86(1-2):134-42. PubMed ID: 7656406
[TBL] [Abstract][Full Text] [Related]
20. Functional and binding studies with muscarinic M2-subtype selective antagonists.
Lazareno S; Roberts FF
Br J Pharmacol; 1989 Sep; 98(1):309-17. PubMed ID: 2804551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
